Stacey Nabors has extensive experience in Regulatory Affairs, particularly in overseeing personnel responsible for various regulatory activities. From preparing and submitting Type II DMFs to coordinating IND submissions for small molecules and biologics, Stacey has proven skills in regulatory compliance and change control evaluations. With a background in Chemistry and Biology, Stacey has managed consultants for CMC activities and demonstrated proficiency in eCTD submission requirements. Additionally, Stacey has experience in overseeing daily cGMP regulatory compliance, FDA correspondences, and IMPD preparation. Through their role at Nektar Therapeutics, Stacey has shown expertise in navigating regulatory processes for pharmaceutical products.
December 1, 2023 - present
December, 2018
March, 2016
February, 2013
June, 2009
April, 2002